{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Ketamine for Migraine in the Emergency Department

Activity Steps

Purpose of Activity

To present historical and recent data surrounding ketamine as an abortive migraine agent for adult patients.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Outline the actions of, indications for, administration of, adverse effects of, and recommendations for ketamine.
  2. Summarize the reported evidence about the use of ketamine to treat migraine symptoms.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: AENJ0420A
Published: Apr/Jun 2020
Expires: 6/3/2022
Required Passing Score: 14/20 (70%)
Authors: Matthew H. Bilhimer, PharmD, BCPS; Meghan E. Groth, PharmD, BCPS; Ashley K. Holmes, PharmD, BCCCP
Topics: Ketamine , Migraine